Medical research equipment and services company Charles River Laboratories International Inc. plans to buy WuXi PharmaTech, a Chinese pharmaceutical outsourcing company, for $1.6 billion.
MannKind Corporation announced that its commercial manufacturing facility, custom-built for the production of its proprietary insulin therapy, has been awarded two Facility of the Year 2010 category awards for process innovation and equipment innovation.
Cresset has announce the appointment of Dr Rob Scoffin as Chief Executive Officer of Cresset Group. Rob replaces Beatrice Leigh, who will now become non-executive Chairman of the Board.
Viruses have evolved a broad range of strategies that enable them to evade the immune systems of their hosts. A team of researchers has been studying a novel, recently discovered mechanism that pathogenic viruses exploit for this purpose.
A New York University study of psychedelic drugs is among a handful now going on in the United States and elsewhere with drugs like LSD, MDMA (Ecstasy) and psilocybin, the main ingredient of "magic mushrooms."
RNA interference (RNAi) is a recently described biologic phenomenon that allows suppression of targeted genes in a highly specific and efficient manner and is being developed as a therapeutic modality with significant medical potential.
Pharmaceutical company AstraZeneca PLC says its schizophrenia drug Seroquel XR has been recommended by European regulators as an add-on treatment for depression.
Genentech, Inc. has submitted a supplemental Biologics License Application to the U.S. Food and Drug Administration for Herceptin plus chemotherapy in people with advanced, HER2-positive adenocarcinoma of the stomach.
Daxas is a proprietary selective phosphodiesterase 4 (PDE4) enzyme inhibitor that has been developed by Nycomed for the treatment of COPD.
Shares of Baxter International plunged after the company cut its full-year profit outlook on slower-than-expected sales of plasma-based drugs and charges related to health care reform.
Pfizer Inc. shareholders overwhelmingly rejected a proposal to stop giving top executives stock options, but the company's CEO still took some heat over that issue and Pfizer's low stock price and reduced profit forecast.
Pharmaceutical maker Novartis AG said the European Union has approved its best-selling hypertension drug Diovan for treatment of children aged 6-18.
Pfizer Inc. said it stopped a late-stage clinical study of its drug Sutent as a treatment for liver cancer.
Federal health experts said overwhelmingly that an experimental painkiller designed to discourage misuse is not effective enough to warrant approval.
Spark Holland’s ultra high pressure pump, the SPH1240, provides 18,000 psi for the entire range of UHPLC analytical flow rates. Accurate flow delivery combined with dedicated adjustment of mixing volume and compressibility compensation guarantee a rapid and reproducible gradient.